胰岛素泵强化治疗对新诊断2型糖尿病的疗效观察

目的观察短期胰岛素泵强化治疗对新诊断2型糖尿病患者血糖达标时间及3个月后复查糖基化血红蛋白的控制情况，从而改变糖尿病的临床进程。方法66例新诊断2型糖尿病患者随机分成两组，治疗组34例，给予2周时间胰岛素强化治疗后，改口服降糖药治疗；对照组32例给予直接口服药治疗，分别观察2组患者血糖达标时间及3个月后糖基化血红蛋白的控制情况。结果治疗组血糖达标达标时间为（2．5±0．8）d，对照组血糖达标时间为（7．5±1．6）d，2组数据比较差异有统计学意义（P〈0．01）。3个月后糖基化血红蛋白情况，治疗组为（5．4±1．5）％，对照组为（6．3±1．8）％，2组数据对照差异有统计学意义（P〈0．05）。结论新诊断2型糖尿病患者，经短期胰岛素泵强化治疗，能缩短血糖达标时间并维持长时间血糖的良好控制。

Observation of insulin pump therapy of newly diagnosed type 2 diabetes patients

Objective Observation of short-term insulin pump therapy of newly diagnosed type 2 diabetes patients with blood glucose target time and 3 months after the review of glycosylated hemoglobin control of the situation. Method 66 cases of newly diagnosed T2DM patients divided into two groups, treatment group 34 cases given two weeks time intensive insulin therapy, and turn into the oral hypoglycemic agent treatment, Control group 32 cases direct oral treatment, 2 groups were observed in patients with blood glucose target and three months. Results Treatment group achieved target blood glucose time of 2. 5 ± 0. 8 days, control group, blood glucose target time 7.5 ± 1.6 days, difference between 2 sets of data have statistical significance （ P 〈 0. 01 ）, three months after the glycation of hemoglobin, the treatment group for 5.4 ± 1.5%, control group was 6. 3 ± 1.8%, 2 sets of data have their differences were statistically significant （P 〈 0. 05 ）. Conclusion Newly diagnosed T2DM by short-term insulin pump therapy can shorten the time of blood glucose targets and maintain good blood sugar control a long time.